NEUROENDOCRINE PROSTATE CANCER (NEPC)
Clinical trials for NEUROENDOCRINE PROSTATE CANCER (NEPC) explained in plain language.
Never miss a new study
Get alerted when new NEUROENDOCRINE PROSTATE CANCER (NEPC) trials appear
Sign up with your email to follow new studies for NEUROENDOCRINE PROSTATE CANCER (NEPC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New CAR t therapy targets tough lung cancers in first human trial
Disease control Not yet recruitingThis early-phase study tests a new treatment called ML261 for people with small cell lung cancer or certain neuroendocrine cancers that have come back or stopped responding to standard therapy. ML261 uses a patient's own immune cells, modified to better recognize and attack cance…
Matched conditions: NEUROENDOCRINE PROSTATE CANCER (NEPC)
Phase: PHASE1 • Sponsor: Moonlight Bio, Inc • Aim: Disease control
Last updated May 26, 2026 08:02 UTC
-
Could a common Alzheimer's drug fight prostate cancer?
Disease control Not yet recruitingThis study tests whether memantine hydrochloride, a drug typically used for Alzheimer's, can help control advanced prostate cancer that has stopped responding to standard treatments. Fifteen men with metastatic castration-resistant prostate cancer will take the drug alongside the…
Matched conditions: NEUROENDOCRINE PROSTATE CANCER (NEPC)
Phase: PHASE2 • Sponsor: Bin Xu • Aim: Disease control
Last updated May 22, 2026 13:54 UTC